In vivo prediction of drug sensitivity with cancer-seeking isotopes.
D000577:Amides / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000378:metabolism; D002279:Carcinoma 256, Walker / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D003857:Deoxyuridine / Q000378:metabolism; D004054:Diethylstilbestrol / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005474:Fluoxymesterone / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007457:Iodine Radioisotopes; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010710:Phosphates / Q000378:metabolism; D051381:Rats; D012711:Serum Albumin, Radio-Iodinated; D012975:Sodium Isotopes; D014226:Triazenes / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000577:Amides; D000970:Antineoplastic Agents; D007093:Imidazoles; D007457:Iodine Radioisotopes; D009607:Nitrosourea Compounds; D010710:Phosphates; D012711:Serum Albumin, Radio-Iodinated; D012975:Sodium Isotopes; D014226:Triazenes; D014750:Vincristine; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D005474:Fluoxymesterone; D005472:Fluorouracil; D003857:Deoxyuridine; D008727:Methotrexate